IndiPharm Clinical Research

Wayne, United States Founded: 2007 • Age: 19 yrs Acquired By Velocity Fund Partners
Clinical development services from Phases I to IV are provided.

About IndiPharm Clinical Research

IndiPharm Clinical Research is a company based in Wayne (United States) founded in 2007 was acquired by Velocity Fund Partners in August 2016.. IndiPharm Clinical Research has raised $5.42 million across 6 funding rounds from investors including Velocity Fund Partners. IndiPharm Clinical Research operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.

  • Headquarter Wayne, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $5.42 M (USD)

    in 6 rounds

  • Latest Funding Round
    $1.06 M (USD), Series A

    Apr 07, 2015

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of IndiPharm Clinical Research

IndiPharm Clinical Research has successfully raised a total of $5.42M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $1.06 million completed in April 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series A — $1.1M
  • First Round

    (12 Feb 2010)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2015 Amount Series A - IndiPharm Clinical Research Valuation

investors

Apr, 2012 Amount Series A - IndiPharm Clinical Research Valuation

investors

Dec, 2011 Amount Debt – Conventional - IndiPharm Clinical Research Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in IndiPharm Clinical Research

IndiPharm Clinical Research has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Velocity Fund Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity investments are directed toward USA-based companies.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by IndiPharm Clinical Research

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - IndiPharm Clinical Research

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Indipharm Clinical Research Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of IndiPharm Clinical Research

IndiPharm Clinical Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapies for cancer and inflammatory diseases are developed.
domain founded_year HQ Location
CRO clinical development services are provided by Syneos Health.
domain founded_year HQ Location
Full-service CRO expertise in influenza and oncology research is offered.
domain founded_year HQ Location
Outsourced contract research organization services are provided to clients.
domain founded_year HQ Location
Full-service clinical research organization services are provided globally by Parexel.
domain founded_year HQ Location
Global full-service CRO services are delivered in over 80 countries.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Indipharm Clinical Research

Frequently Asked Questions about IndiPharm Clinical Research

When was IndiPharm Clinical Research founded?

IndiPharm Clinical Research was founded in 2007 and raised its 1st funding round 3 years after it was founded.

Where is IndiPharm Clinical Research located?

IndiPharm Clinical Research is headquartered in Wayne, United States.

Is IndiPharm Clinical Research a funded company?

IndiPharm Clinical Research is a funded company, having raised a total of $5.42M across 6 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $200K, raised on Feb 12, 2010.

What does IndiPharm Clinical Research do?

Indipharm is a Clinical Research Operations providing firm with full FDA and EMA compliance. The firm has competencies along assistance in Therapeutic areas, Clinical Research services, Site management and Pharmacovigilance. Their Pharmacovigilance services provides integrated drug safety services to support others compounds or devices in development. Some of the services offered are: Proof of Concept Studies, Phase I-IV Efficacy studies, QA Auditing, Regulatory Consulting, Medical Writing etc. The company has been relaunched as InClinica after its acquisition by Velocity Fund Partners in August 2016.

Who are the top competitors of IndiPharm Clinical Research?

IndiPharm Clinical Research's top competitors include Emmes, Syneos Health and ClinChoice.

Who are IndiPharm Clinical Research's investors?

IndiPharm Clinical Research has 1 investor. Key investors include Velocity Fund Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available